Moshe Arkin

Investment holding company

Develops and commercializes proprietary biochemical regulatory therapeutics

Engages in non-invasive solutions for the prevention of venous thromboembolism

Develops spine surgery instrumentation and implants for treating degenerative spinal conditions

Manufactures and packages vitamins, minerals, supplements, and licensed medicines

Manufactures gastrointestinal diagnostic systems for diagnosing and managing in the fields of liver and GI health

Accelmed Partners invests in lower middle market companies located in the United States and Europe. The firm targets companies operating in the fields of medical devices, diagnostics, digital health and technology enabled services. It provides financing for buyout and growth stage capital requirements with an investment size of USD 20 - 40 million. The firm acquires controlling and non-controlling interests and makes co-investments. It acts as a lead investor and takes a seat on the board of directors and also makes follow on investments.

Develops and manufactures generic pharmaceuticals and active pharmaceutical ingredients

Discovers, develops and markets novel immunotherapy to treat cancer

Develops a proprietary nanoparticle-based delivery system for the targeted delivery of chemotherapy and anti-inflammatory drugs

Accelmed Ventures invests in companies located in the US. The firm focuses on broad range of sectors. It participated in seed and early stage capital transactions.

Engages in the designing, developing and commercializing devices and accessories for minimally invasive treatment of heart valve diseases

Develops novel endovascular system for endovascular aortic aneurysm repair

Develops therapy for diseases such as cancer

Develops solutions to metabolic diseases

Develops intravascular ultrasound systems

Develops intimate skin patch for the treatment of premature ejaculation

Arkin Bio focuses its investment efforts in life science companies located across the globe, mainly in Israel. The firm targets businesses operating in the biotechnology and pharmaceutical sector. It provides financing for early to mid-stage capital requirements.